Nantahala Capital Management, LLC Savara Inc Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
A detailed history of Nantahala Capital Management, LLC transactions in Savara Inc stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 7,525,259 shares of SVRA stock, worth $20.2 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
7,525,259
Previous 5,180,951
45.25%
Holding current value
$20.2 Million
Previous $22 Million
5.17%
% of portfolio
1.16%
Previous 1.3%
Shares
5 transactions
Others Institutions Holding SVRA
# of Institutions
141Shares Held
158MCall Options Held
55.6KPut Options Held
600-
Nea Management Company, LLC Timonium, MD24.5MShares$65.8 Million5.37% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA14.6MShares$39.2 Million12.07% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA12.4MShares$33.3 Million6.2% of portfolio
-
Vestal Point Capital, LP New York, NY10.8MShares$29 Million1.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.66MShares$23.3 Million1.59% of portfolio
About Savara Inc
- Ticker SVRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 114,043,000
- Market Cap $307M
- Description
- Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.